Motaz Qadan was named surgeon-in-chief for the Mass General Brigham Cancer Institute, effective Aug. 17.
At the end of July, after just a few months as director of the Center for Biologics Evaluation and Research, Vinay Prasad resigned.
Motaz Qadan named surgeon-in-chief at Mass General Brigham Cancer Institute
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
YOU MAY BE INTERESTED IN
John C. Byrd, a physician scientist who specializes in hematologic malignancies, was appointed director of UPMC Hillman Cancer Center.
Richard L. Schilsky has left his role as inaugural principal investigator of the American Society of Clinical Oncology-led Targeted Agent and Profiling Utilization Registry study after a decade of leadership.
Catheryn Yashar, chief medical officer and breast and gynecologic cancer radiation oncologist at UC San Diego Health, was appointed president-elect of the American Society for Radiation Oncology.
Alice T. Shaw was named chair of the Department of Medical Oncology at Dana-Farber Cancer Institute.
Weizhou Zhang, a researcher in the fields of breast cancer and cancer immunotherapy, was appointed co-leader of the UF Health Cancer Center’s Mechanisms of Oncogenesis research program.
